ATC codes: Pending
Chronic hepatitis C ICD11 code: 1E91.1
Pangenotypic when used in combination with sofosbuvir.
Oral > Solid > tablet: 200 mg
EML status history
Adolescents and adults
Medicines within the same pharmacological class can be used
Therapeutic alternatives limitations
Pangenotypic direct-acting antiviral combinations
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the inclusion of ravidasvir on the core list of the EML as a therapeutic alternative under the square box listing for pangenotypic direct-acting antivirals for the treatment of chronic hepatitis C virus infection in adults. Ravidasvir is pangenotypic when used in combination with sofosbuvir. The recommendation was made based on evidence of effectiveness and safety, similar to that seen with other pangenotypic direct-acting antiviral regimens.